WORX SCWorx Corp.
$3.66▲ +36.57%
Healthcare
Other
Volume 77.85M
Avg Volume (10D) 13.78M
Key Metrics & Fundamentals
Market Cap
$1.98M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.07 - 118.26
% vs 50 MA
-12.57%
% vs 200 MA
-76.83%
RSI-14
50.2
MACD Histogram
-0.1100
Beta (1Y vs SPY)
-0.29
Free Cash Flow
-$78,301
Gross Rev
$706,049
Gross Profit
$330,423
EBITDA
-$120,068
COGS
$375,626
Operating Exp
$451,377
Operating Income
-$120,954
EBIT
-$120,954
Pretax Income
-$120,954
Net Income
-$120,954
EPS (Diluted)
-1.35
Price & Volume History
Loading chart…
Recent News
SCWorx Announces New Agreement with Healthcare System
GlobeNewswire · Oct 19, 2026 10:10 AM ET
Top Premarket Decliners
MT Newswires · Oct 12, 2026 7:22 AM ET
SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy
GlobeNewswire · Oct 7, 2026 2:23 PM ET
SCWorx Announces Nasdaq Trading to Resume October 7, 2026
GlobeNewswire · Oct 6, 2026 2:17 PM ET
SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market
GlobeNewswire · Oct 5, 2026 1:07 PM ET
SCWorx Announces Equity Financing with Institutional Investors
GlobeNewswire · Sep 17, 2026 9:07 AM ET
SCWorx Announces New Two-Year Agreement with One of Massachusetts’ Largest Integrated Delivery Networks
GlobeNewswire · Aug 6, 2026 11:03 AM ET
SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market
GlobeNewswire · Jul 29, 2026 10:15 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See WORX's money flow as a full page
Social Sentiment
No Reddit posts found for WORX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.